Press release
Leading Element Driving Change in the Pontine Glioma Drugs Market in 2025: Role of Personalized Medicine in Driving Growth Of The Pontine Glioma Drugs Market Driver
Pontine Glioma Drugs
The growing demand for personalized medicine is expected to propel the growth of the pontine glioma drugs market. Personalized medicine tailors treatments based on an individual's unique characteristics, improving the effectiveness of therapies. For instance, in 2023, the FDA approved 16 new personalized therapies for rare diseases, showing a significant increase in treatments for conditions like pontine gliomas. As a result, the rise of personalized medicine is driving the growth of the pontine glioma drugs market.
Get Your Pontine Glioma Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/pontine-glioma-drugs-global-market-report
What is the future CAGR of the pontine glioma drugs market, and how will it impact industry expansion?
The pontine glioma drugs market has grown rapidly in recent years. It will expand from $0.98 billion in 2024 to $1.09 billion in 2025, at a CAGR of 11.3%. The growth is due to increasing awareness and acceptance, advancements in medical imaging, and ongoing research efforts and clinical trials.
The pontine glioma drugs market is expected to grow to $1.66 billion by 2029, at a CAGR of 11.1%. Growth is attributed to advancements in precision medicine, global collaborations, immunotherapy innovations, and targeted therapies. Major trends include continued advancements in immunotherapy, nanotechnology, gene therapy, combination therapies, and the evolving regulatory landscape.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15899&type=smp
What are the most significant trends transforming the pontine glioma drugs market today?
Companies in the pontine glioma drugs market are focusing on creating new products, such as small-molecule chemotherapeutics, to increase their market revenues. These drugs are low molecular weight compounds that can pass through the blood-brain barrier and target tumors in pontine glioma. For example, in December 2022, Kintara Therapeutics, a clinical-stage drug development company in the U.S., received orphan drug designation from the U.S. FDA for its drug, VAL-083, intended for treating diffuse intrinsic pontine glioma (DIPG). VAL-083 is a first-in-class small-molecule chemotherapeutic with a unique action mechanism and has shown clinical efficacy in treating several cancers, including central nervous system, ovarian, and other solid tumors. This designation highlights VAL-083's potential for treating this difficult brain tumor, reinforcing efforts to meet unmet medical needs in DIPG treatment.
Which key market segments comprise the pontine glioma drugs market and drive its revenue growth?
The pontine glioma drugs market covered in this report is segmented -
1) By Type: Diffuse Brain Stem Glioma, Focal Brain Stem Glioma, Recurrent Brain Stem Glioma
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
3) By Application: Cancer Research Institutes, Diagnostic Laboratories, Hospitals
Subsegments:
1) By Diffuse Brain Stem Glioma: Chemotherapy Treatments, Targeted Therapy, Immunotherapy Drugs
2) By Focal Brain Stem Glioma: Surgical Intervention Drugs, Radiation Therapy Drugs, Chemotherapy Agents
3) By Recurrent Brain Stem Glioma: Experimental Drug Therapies, Combination Chemotherapy, Personalized Medicine Approaches
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15899
What regions are at the forefront of pontine glioma drugs market expansion?
North America was the largest region in the pontine glioma drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pontine glioma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the leading players fueling growth in the pontine glioma drugs market?
Major companies operating in the pontine glioma drugs market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Teva Pharmaceutical Industries, Daiichi Sankyo Company Limited, The Menarini Group, Y-mAbs Therapeutics, Agios Pharmaceuticals, Kazia Therapeutic, DNAtrix Inc., Aminex Therapeutics Inc., Accendatech Co Ltd., Arog Pharmaceuticals, Kintara Therapeutics Inc., Medicenna Therapeutics, Alaunos Therapeutics, Biodexa Pharmaceuticals PLC
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15899&type=smp
What Is Covered In The Pontine Glioma Drugs Global Market Report?
•Market Size Forecast: Examine the pontine glioma drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the pontine glioma drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the pontine glioma drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pontine glioma drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the pontine glioma drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pontine glioma drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the pontine glioma drugs market.
•Competitive Landscape: Review strategic developments in the pontine glioma drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Element Driving Change in the Pontine Glioma Drugs Market in 2025: Role of Personalized Medicine in Driving Growth Of The Pontine Glioma Drugs Market Driver here
News-ID: 3931914 • Views: …
More Releases from The Business Research Company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for Glioma
Glioma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Glioma Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Glioma pipeline landscape. It covers the Glioma Pipeline Drug profiles, including clinical and nonclinical stage products. It also covers the Glioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances…
Glioma Competitive Landscape 2023 (Updated)
DelveInsight's, "Glioma Competitive Landscape 2023" report provides comprehensive insights about 200+ Glioma companies and 220+ drugs in Glioma Competitive landscape. It covers the Glioma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioma Competitive Landscape Report
• DelveInsight's Glioma report depicts a robust space with 200+ Glioma companies working to develop 220+ pipeline therapies…
Low-Grade Glioma Therapeutics Market - Transforming Futures, Defying Low-Grade G …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Low-Grade Glioma Therapeutics Market.
Low-Grade Glioma Therapeutics Market: https://www.growthplusreports.com/report/lowgrade-glioma-therapeutics-market/9187
The Low-Grade Glioma Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Adult Malignant Glioma Therapeutics Market - Defying the Tumor, Empowering Survi …
Newark, New Castle, USA - new report, titled Adult Malignant Glioma Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Adult Malignant Glioma Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Adult Malignant Glioma Therapeutics market. The report offers…
Glioma pipeline involves 150+ key companies continuously working towards develop …
DelveInsight's, "Glioma Pipeline Insight, 2023," report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in Glioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioma Pipeline Report
• DelveInsight's glioma pipeline report depicts a…
Rising Number of People Diagnosed with Malignant Glioma Supports the Growth of t …
Glioma is a type of tumor that occurs in brain or spine. It is a group of brain tumor that includes oligodendrogliomas and astrocytomas. Gliomas include all types of brain tumors arising from supportive tissue of the brain. Malignant glioma is the most common type of brain tumor observed in adults globally. Collectively they contribute around 40% of the total cases diagnosed with brain tumor. In the last decade, there…
